Clinical Pharmacology of Statins: an Update

被引:28
作者
Ferri, Nicola [1 ]
Corsini, Alberto [2 ,3 ]
机构
[1] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo Egidio Meneghetti 2, I-35131 Padua, Italy
[2] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy
[3] IRCCS Multimed, Milan, Italy
关键词
Statins; PCSK9; Ezetimibe; Bempedoic acid; Evolocumab; Alirocumab; Inclisiran; DENSITY-LIPOPROTEIN CHOLESTEROL; LOWERING LDL CHOLESTEROL; 20-YEAR FOLLOW-UP; PRIMARY PREVENTION; CARDIOVASCULAR RISK; BEMPEDOIC ACID; 80; MG; THERAPY; METAANALYSIS; EFFICACY;
D O I
10.1007/s11883-020-00844-w
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of ReviewStatins represent the cornerstone for the treatment of hypercholesterolemia, although muscle-related side effects and dysregulation of glucose metabolism have strongly limited their adherence and compliance especially in primary prevention therapy. The purpose of the present review is to provide the most recent evidence of the efficacy and safety of statins in monotherapy or combination with new lipid-lowering drugs.Recent FindingsRecent "life-long" analysis conducted on young familial hypercholesterolemia patients, elderly hypocholesterolemic subjects, and from a 20-year follow-up of randomized controlled trial (RCT) have been published confirming that the cardiovascular benefits of statin therapy, in patients for whom it is recommended by current guidelines, greatly outweigh the risks of side effects. In addition, recent therapies to be used in combination with statins have shown to increase the percentage of patients at goal for low-density lipoprotein - cholesterol (LDL-C) with a good safety profile. The cardiovascular (CV) benefits of monoclonal antibodies anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) and ezetimibe, in patients under statin therapy, have been proven by specific RCT, while we are still waiting for the results of bempedoic acid and the small-interfering RNA (si-RNA) anti-PCSK9 inclisiran.SummaryTaken together, the approval of new pharmacological agents to be used in combination with statins represents the future for a tailored therapy of cardiovascular disease patients.
引用
收藏
页数:9
相关论文
共 71 条
[1]   Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption [J].
Altmann, SW ;
Davis, HR ;
Zhu, LJ ;
Yao, XR ;
Hoos, LM ;
Tetzloff, G ;
Iyer, SPN ;
Maguire, M ;
Golovko, A ;
Zeng, M ;
Wang, LQ ;
Murgolo, N ;
Graziano, MP .
SCIENCE, 2004, 303 (5661) :1201-1204
[2]   Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention [J].
Amarenco, Pierre ;
Labreuche, Julien .
LANCET NEUROLOGY, 2009, 8 (05) :453-463
[3]   Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial [J].
Armitage, Jane ;
Bowman, Louise ;
Wallendszus, Karl ;
Bulbulia, Richard ;
Rahimi, Kazem ;
Haynes, Richard ;
Parish, Sarah ;
Peto, Richard ;
Collins, Rory ;
Meade, T. ;
Sleight, P. ;
Collins, R. ;
Armitage, J. ;
Bowman, L. ;
Parish, S. ;
Peto, R. ;
Barton, J. ;
Bray, C. ;
Wincott, E. ;
Dayanandan, R. ;
Clarke, R. ;
Graham, I. ;
Simpson, D. ;
Warlow, C. ;
Wilken, D. ;
Tobert, J. ;
Mushner, T. ;
Doll, R. ;
Wilhelmsen, L. ;
Fox, K. ;
Hill, C. ;
Sandercock, P. ;
Webster, J. ;
Henderson, J. ;
Nixon, A. ;
Lackie, S. ;
Thompson, J. ;
Brown, M. ;
Blackwood, S. ;
Morgan, M. ;
Rhoden, W. ;
Saeed, B. ;
Houghton, M. ;
Nicholson, A. ;
Simpson, C. ;
Hoburn, B. ;
Cooper, I. ;
Gallivan, A. ;
Pickerell, E. ;
Hancock, J. .
LANCET, 2010, 376 (9753) :1658-1669
[4]  
Arnaboldi L, 2015, ATHEROSCLEROSIS SUPP, V16, P1, DOI 10.1016/S1567-5688(14)70002-9
[5]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[6]   The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].
Baigent, Colin ;
Landray, Martin J. ;
Reith, Christina ;
Emberson, Jonathan ;
Wheeler, David C. ;
Tomson, Charles ;
Wanner, Christoph ;
Krane, Vera ;
Cass, Alan ;
Craig, Jonathan ;
Neal, Bruce ;
Jiang, Lixin ;
Hooi, Lai Seong ;
Levin, Adeera ;
Agodoa, Lawrence ;
Gaziano, Mike ;
Kasiske, Bertram ;
Walker, Robert ;
Massy, Ziad A. ;
Feldt-Rasmussen, Bo ;
Krairittichai, Udom ;
Ophascharoensuk, Vuddidhej ;
Fellstrom, Bengt ;
Holdaas, Hallvard ;
Tesar, Vladimir ;
Wiecek, Andrzej ;
Grobbee, Diederick ;
de Zeeuw, Dick ;
Gronhagen-Riska, Carola ;
Dasgupta, Tanaji ;
Lewis, David ;
Herrington, William ;
Mafham, Marion ;
Majoni, William ;
Wallendszus, Karl ;
Grimm, Richard ;
Pedersen, Terje ;
Tobert, Jonathan ;
Armitage, Jane ;
Baxter, Alex ;
Bray, Christopher ;
Chen, Yiping ;
Chen, Zhengming ;
Hill, Michael ;
Knott, Carol ;
Parish, Sarah ;
Simpson, David ;
Sleight, Peter ;
Young, Alan ;
Collins, Rory .
LANCET, 2011, 377 (9784) :2181-2192
[7]  
Björnsson E, 2012, J HEPATOL, V56, P374, DOI [10.1016/j.jhep.2011.08.016, 10.1016/j.jhep.2011.07.023]
[8]   Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].
Cannon, Christopher P. ;
Blazing, Michael A. ;
Giugliano, Robert P. ;
McCagg, Amy ;
White, Jennifer A. ;
Theroux, Pierre ;
Darius, Harald ;
Lewis, Basil S. ;
Ophuis, Ton Oude ;
Jukema, J. Wouter ;
De Ferrari, Gaetano M. ;
Ruzyllo, Witold ;
De Lucca, Paul ;
Im, KyungAh ;
Bohula, Erin A. ;
Reist, Craig ;
Wiviott, Stephen D. ;
Tershakovec, Andrew M. ;
Musliner, Thomas A. ;
Braunwald, Eugene ;
Califf, Robert M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397
[9]   Long-Term Persistence with Statin Treatment in a Not-for-Profit Health Maintenance Organization: A Population-Based Retrospective Cohort Study in Israel [J].
Chodick, Gabriel ;
Shalev, Varda ;
Gerber, Yariv ;
Heymann, Anthony D. ;
Silber, Haim ;
Simah, Virginia ;
Kokia, Ehud .
CLINICAL THERAPEUTICS, 2008, 30 (11) :2167-2179
[10]   Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences [J].
Chowdhury, Rajiv ;
Khan, Hassan ;
Heydon, Emma ;
Shroufi, Amir ;
Fahimi, Saman ;
Moore, Carmel ;
Stricker, Bruno ;
Mendis, Shanthi ;
Hofman, Albert ;
Mant, Jonathan ;
Franco, Oscar H. .
EUROPEAN HEART JOURNAL, 2013, 34 (38) :2940-2948